🇺🇸 FDA
Patent

US 7101964

Intermediate for preparing glycopeptide derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 7101964 (Intermediate for preparing glycopeptide derivatives) held by Theravance, Inc. expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P31/04